World
Pfizer vaccine raises 'no specific safety concerns': US regulator
- Data from 38,000 trial participants involved in testing the Pfizer-BioNTech Covid-19 vaccine revealed "no specific safety concerns,"
1 min
By
WASHINGTON: Data from 38,000 trial participants involved in testing the Pfizer-BioNTech Covid-19 vaccine revealed "no specific safety concerns," a document issued by the US Food and Drug Administration (FDA) said Tuesday.